Clinical Trial Update: A Clinical Trial to Evaluate the Recombinant Human Type5 Adenovirus Vector Based Ebola Virus Disease Vaccine [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 2 evaluation of a recombinant human adenovirus type 5 vector–based Ebola vaccine for Ebola virus di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Drugs mentioned

• Recombinant human adenovirus type 5 vector Ebola vaccine

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Ebola Disease | Phase 2 | Status: COMPLETED